Novo Nordisk Symbol - Search News

Hims & Hers plunges as the FDA says Novo’s weight loss drugs are not in shortage

Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisk's (NVO) weight loss therapies are no longer in shortage in the U.S. Read more here.

Business Insider · 15h

Shortage of Novo Nordisk’s (NVO) Weight Loss Drugs Is Resolved, Says FDA

The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration

Investor's Business Daily on MSN · 11h

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss and diabetes drugs has been resolved. The FDA website indicated that the shortage of Novo Nordisk's Ozempic and Wegovy has ended.

Seeking Alpha4d

NVO Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

Hosted on MSN16d

Novo Nordisk Stock Jumps On Q4 Beat: Retail Brushes Off Slower Growth Outlook To Chase Obesity Drug Boom

NYSE-listed shares of Novo Nordisk surged 4% on Wednesday morning after the Danish pharmaceutical giant posted better-than-expected fourth-quarter earnings. The company reported earnings of 6.34 ...

Nasdaq21d

See Which Of The Latest 13F Filers Holds Novo-Nordisk

At Holdings Channel, we have reviewed the latest batch of the 22 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Novo-Nordisk AS (Symbol: NVO) was held by 9 of ...

Yahoo Finance28d

Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin

Novo Nordisk's stock (NVO) rose more than 8% in Friday trading on news that the company's latest weight-loss product delivered favorable results. The new drug, amycretin, similar to the company's ...

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results